EDITION:
- EU
- NA
CANNAVIGIA (by Vigia AG), a global pioneer in cannabis compliance software and consulting, is expanding its presence in the U.S. market, building on recent regulatory developments related to the potential rescheduling of medical cannabis to Schedule III.
Responsibility for all medical cannabis policy and regulation should sit with the Department of Health and Social Care (DHSC), according
Oxford Cannabinoid Technologies (“OCT” or “the Company”) is pleased to announce the successful completion of ‘proof of concept’ of its
The NHS is failing to prescribe cannabis flower medication to any patients, including those with conditions such as epilepsy, chronic pain, and cancer, according to new research from the Cannabis Industry Council (CIC).
Allowing medical cannabis to be prescribed on the NHS for chronic pain could save the state healthcare provider almost £4 billion annually, according to a new research study.
New Zealand’s largest producer of medicinal cannabis, Helius Therapeutics, has launched in the Australian market under the brand HTL. On
UK Clinics Collaborate for Series of Nationwide Events to Celebrate and Discuss Medical Cannabis in the UK. In celebration of
SOMAÍ Pharmaceuticals is proud to announce a strategic partnership with Releaf, the UK’s fastest-growing medical cannabis clinic, to bring innovative
Polish medical cannabis company Hemp&Health (WSE:HMP) signed an agreement to acquire a 5% stake in the Portuguese company Hibisco Discreto,
LeafLink, the nation’s leading cannabis wholesale platform, today announced Payment on Sell Through (PoST), a first-of-its-kind payment option for cannabis
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
